U.S. Retail REITs Stock News

AES stock has delivered a weak overall result over the past five years, yet several valuation checks now suggest the current share price may sit below what its cash flows imply. The question for investors is whether AES is a genuine value opportunity or simply reflecting the challenges embedded in its recent track record. The share price is down about 26.4% over the last five years, which points to a period where long term holders have not been rewarded. Expectations for future cash...

Why the ALKIVIA results matter for Zai Lab stock Zai Lab (ZLAB) stock action is currently anchored to fresh clinical data from the ALKIVIA Phase 3 trial of VYVGART Hytrulo in autoimmune myositis, which met its primary endpoint with statistically significant results. The study showed a 15.4 point greater improvement in Total Improvement Score at Week 52 versus placebo in the combined immune mediated necrotizing myopathy and dermatomyositis population, with benefits emerging by Week 4 and...

AXT stock has delivered an extremely strong run over the past few years, yet the latest valuation checks suggest the shares now lean expensive rather than offering clear value. After such a sharp move, investors are weighing the recent gains against what the broader valuation signals and fundamentals imply for risk and reward. Over the past 3 years, AXT has returned about 24x, which puts a spotlight on how much future growth is already reflected in the share price. Expectations that higher...

Acadia Pharmaceuticals has received European Commission marketing authorization for DAYBU (trofinetide) to treat neurobehavioral symptoms of Rett syndrome in patients aged five and older across the European Union, Iceland, Liechtenstein, and Norway, based on Phase 3 LAVENDER data showing statistically significant and clinically meaningful improvements on key clinical scales. This approval makes DAYBU the first and only authorized therapy for Rett syndrome in the EU, potentially opening a new...

Guidewire Software recently reported earnings for the quarter ended July 2026, delivering year-over-year growth in both earnings and revenue after earlier caution from analysts. The negative Earnings ESP ahead of the release highlighted growing analyst uncertainty, making the subsequent earnings call a focal point for understanding business conditions and expectations. With mixed analyst sentiment highlighted by the negative Earnings ESP, we’ll now examine how this earnings setup shapes...

Plug Power stock has delivered a very weak long term result, with the share price down about 91.6% over the past 5 years. However, current valuation checks still point to an expensive profile rather than a clear bargain. Recent price gains and ongoing news around project cancellations and funding challenges keep attention on whether the current market value matches the company’s risk and return trade off. Over 5 years, Plug Power shares have fallen about 91.6%, which signals that long term...

Why Owens Corning stock is back on investors’ radar Owens Corning (OC) has drawn fresh attention after brokerage research pointed to an average recommendation that sits between Strong Buy and Buy, supported by higher earnings estimates and a Zacks Rank #2 rating. The share price of Owens Corning closed at US$143.68, with short term momentum softening after a 1-day share price return that declined 1.39% and a 7-day share price return that declined 2.36%, even as the 90-day share price return...

Incyte recently reported past second-quarter 2026 results that exceeded earnings and revenue expectations, supported by strong demand for Jakafi and Opzelura, and raised its 2026 net product revenue guidance. The FDA’s approval of Niktimvo for chronic graft-versus-host disease adds another commercial therapy to Incyte’s portfolio, potentially broadening its revenue base beyond Jakafi. Next, we’ll explore how the raised 2026 revenue guidance, underpinned by Opzelura demand, reshapes Incyte’s...

Cigna Group (CI) just announced a connected benefits solution for employees on high-deductible health plans, linking medical and supplemental coverage to simplify claims and speed up access to cash benefits after covered health events. Cigna Group’s connected benefits launch comes as the stock consolidates after a mixed stretch, with the share price down about 7.8% over the past month but roughly flat over 90 days. Total shareholder return of about 39.5% over five years points to steadier...

Dollar General (NYSE: DG) reported a strong second quarter with significant growth in net income and same store sales. The company raised its full year earnings guidance following the quarterly results. Dollar General announced a new AI driven supply chain partnership with RELEX Solutions to support forecasting, replenishment, and allocation. For a wider view on how AI driven operations are shaping opportunities beyond Dollar General, explore the companies grouped in 55 AI infrastructure...

With no single headline event driving attention, interest in Upbound Group (UPBD) today centers on how the stock’s recent performance and valuation metrics compare with its current profitability and revenue profile. At a share price of $19.29, Upbound Group has seen short term momentum soften, with the 30 day share price return down 10.65% after a 7 day share price gain of 4.05%. The 1 year total shareholder return is down 19.12% and the 5 year total shareholder return is down 60.06%,...

Victory Capital Holdings (NasdaqGS:VCTR) agreed to acquire First Eagle Investments in a US$7b transaction. The combined company will oversee about US$571b in assets under management once the deal closes. The acquisition adds CLOs and alternative credit strategies to Victory Capital's product lineup and broadens its global reach. The transaction highlights ongoing consolidation in the asset management industry as firms respond to fee pressure. Investors following Victory Capital's move into...

Suburban Propane Partners has delivered a 66.7% total return over the past 5 years, yet the current share price still screens as cheap on broader valuation checks. Recent share price softness over the past month and year to date contrasts with that longer run, which makes the current pricing worth a closer look for income focused investors. Over 5 years, Suburban Propane Partners has returned 66.7%, which indicates that long term holders have already seen a meaningful payoff from staying...

NetApp stock has delivered a strong share price run over the past few years, while the latest valuation checks show a split between an intrinsic value estimate that points to some upside and broader metrics that lean expensive. With the market price near recent highs, investors are weighing how much of the recent optimism is already reflected in the current valuation. NetApp has returned 163.5% over the past 3 years, which puts extra focus on whether the current price still offers a...

Intercontinental Exchange (ICE) recently updated its financing arrangements, extending its multi currency revolving credit facility and adding new MarketAxess linked commitments, alongside a fresh term loan that supports the pending MarketAxess Holdings acquisition. At a share price of US$161.24, Intercontinental Exchange has seen a 30 day share price return of 5.58% and a 90 day share price return of 9.06%, while the 1 year total shareholder return has declined 7.81%. Recent momentum...

Berkshire Hathaway stock is being priced at about a one third discount to an intrinsic value estimate from the Excess Returns model, even though the share price has already delivered a 76.7% gain over the past 5 years. For investors, the puzzle is why a company with that track record still looks cheap across several valuation checks. Over the past 5 years, Berkshire Hathaway has returned 76.7%, which points to solid long term wealth creation for shareholders who stayed invested through that...

Why Star Bulk Carriers Stock Is On Investors’ Radar Today Star Bulk Carriers (NasdaqGS:SBLK) has drawn fresh attention after its recent share price move, with the stock closing at $30.42. Investors are weighing this against the company’s dry bulk shipping footprint and earnings profile. Over the past year, Star Bulk Carriers has combined a 57.05% year to date share price return with a 1 month share price return of 8.64% and a 1 year total shareholder return of 72.01%, which points to building...

The United States market has shown a steady upward trend, increasing by 1.2% over the last week and climbing 18% in the past year, with earnings projected to grow by 17% annually. In this environment, identifying stocks that are potentially undervalued can provide intrinsic value opportunities for investors seeking to capitalize on these positive market conditions.

The United States market has shown positive momentum, with a 1.2% increase over the last week and an impressive 18% rise over the past year, while earnings are projected to grow by 17% annually. In this favorable environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment of interests between shareholders and management.

The United States market has experienced a positive trend, rising 1.2% over the last week and 18% over the past year, with earnings forecasted to grow by 17% annually. In this context of growth, identifying stocks with strong financial health is crucial for investors seeking potential opportunities. Although penny stocks may seem like a relic of earlier market days, they continue to offer intriguing possibilities for growth in smaller or newer companies when backed by solid fundamentals and...

Why MKS Stock Is Back On Investor Radars Recent analyst revisions to earnings forecasts for MKS (MKSI) have become the key catalyst drawing fresh attention to the stock. Consensus expectations for both the upcoming quarter and full year have been adjusted higher. Despite the recent pullback, with the share price down 16.4% over the past 90 days and 5% over the past month to US$270.99, MKS still carries strong long-term momentum, reflected in a 153.1% 1-year total shareholder return that...

What Recent Performance Says About Omnicell Stock Omnicell (OMCL) has drawn investor attention after a period of weaker share performance, with the stock down about 22% over the past month and roughly 24% over the past 3 months. This recent decline contrasts with a market value of about US$1.53b and annual revenue of US$1.25b. These figures give investors a concrete starting point to size up the business against its current share price. Omnicell’s recent slide fits into a wider losing streak,...

In late August 2026, Onto Innovation was highlighted by Zacks with a Rank #1 (Strong Buy) after analysts raised current-year earnings estimates by about 10% over the prior 60 days. The company also earned an Average Brokerage Recommendation near the Strong Buy range and an A-grade momentum score, signaling unusually broad analyst agreement on improving earnings prospects. Next, we’ll explore how this broad-based analyst optimism and earnings estimate uplift might influence Onto...

Braze, Inc. recently appointed Pearce Dolan as Chief Product Officer, bringing nearly 20 years of product and technology leadership experience from roles at Deel and Revolut to oversee product strategy under CEO Bill Magnuson. The hire underscores Braze’s focus on advancing AI-driven customer engagement, adding a leader with a track record of scaling complex, multi-product platforms across HR, fintech, and payroll services. Next, we’ll examine how Dolan’s AI-focused product leadership could...